http://www.cbc.ca/health/story/2010/03/25/gabapentin-ubc.html
Pharmaceutical giant Pfizer has been ordered to pay $142 million US in damages for fraudulently marketing gabapentin, an anti-seizure drug marketed under the name Neurontin.
Sunday, March 28, 2010
Subscribe to:
Posts (Atom)
Posts
